AbCellera Biologics ABCL
NASDAQ ABCL
$13.92 +1.22 (+9.61%)
At close: Sep 28, 2026 · 4:00 PM EDT

AbCellera Biologics (ABCL) EV to EBIT (2020 - 2022)

Updated

AbCellera Biologics' EV to EBIT came in at 9.40 for Q4 2022, down 42.2% from 16.27 a year earlier but up 61.2% from the prior quarter.

Analysis

AbCellera Biologics (ABCL) EV to EBIT (2020 - 2022) Analysis & Trends

Going back to Q4 2020, AbCellera Biologics' EV to EBIT data covers 9 quarters.

  • Going back by year, EV to EBIT was 16.28 in FY2021 (-56.3%) and 37.25 in FY2020.
  • The five-year range for quarterly EV to EBIT is 5.83 (Q3 2022) to 37.25 (Q4 2020).
  • Year-over-year, EV to EBIT has declined for five consecutive quarters, with an average decline of 59.1% over the last five quarters.
  • Business Quant data shows ABCL's EV to EBIT at 5.83 (Q3 2022), 7.46 (Q2 2022) and 7.33 (Q1 2022) in the three quarters before Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn
10 AbCellera Biologics 3.89 Bn 3.89 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 9.40
Sep 30, 2022 5.83
Jun 30, 2022 7.46
Mar 31, 2022 7.33
Dec 31, 2021 16.27
Sep 30, 2021 18.03
Jun 30, 2021 17.10
Mar 31, 2021 26.93
Dec 31, 2020 37.25
API Access

AbCellera Biologics EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=ABCL&period=max&api_key=YOUR_API_KEY